These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1695357)

  • 1. A study of the use of flecainide acetate in the long-term management of cardiac arrhythmias.
    Wiseman MN; Elstob JE; Camm AJ; Nathan AW
    Pacing Clin Electrophysiol; 1990 Jun; 13(6):767-75. PubMed ID: 1695357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.
    Hohnloser SH; Zabel M
    Am J Cardiol; 1992 Aug; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy and safety of flecainide for supraventricular tachycardia.
    Neuss H; Schlepper M
    Am J Cardiol; 1988 Aug; 62(6):56D-61D. PubMed ID: 3136637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flecainide in the Wolff-Parkinson-White syndrome.
    Crozier I
    Am J Cardiol; 1992 Aug; 70(5):26A-32A. PubMed ID: 1509995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Flecainide and anti-arrhythmia therapy].
    Croce L; Romano S; Pozzoni L; Lomuscio A
    Minerva Med; 1988 Mar; 79(3):229-34. PubMed ID: 3129677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ
    Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
    Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of flecainide acetate for refractory junctional tachycardias in children with the Wolff-Parkinson-White syndrome.
    Ward DE; Jones S; Shinebourne EA
    Am J Cardiol; 1986 Apr; 57(10):787-90. PubMed ID: 3962866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term evaluation of flecainide acetate in supraventricular tachyarrhythmias.
    Mary-Rabine L; Telerman M
    Acta Cardiol; 1988; 43(1):37-48. PubMed ID: 3132008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Our experience with flecainide acetate in resistant arrhythmias in children. Apropos of 35 cases].
    Denjoy I; Lucet V; Do Ngoc D; Magnier S; Casasoprana A; Coumel P
    Arch Mal Coeur Vaiss; 1991 May; 84(5):647-52. PubMed ID: 1910326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of flecainide acetate in rapid atrial fibrillation complicating Wolff-Parkinson-White syndrome.
    Kappenberger LJ; Fromer MA; Shenasa M; Gloor HO
    Clin Cardiol; 1985 Jun; 8(6):321-6. PubMed ID: 4006340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flecainide acetate in the treatment of supraventricular tachycardias: value of programmed electrical stimulation for long-term prognosis.
    van Wijk LM; Crijns HJ; van Gilst WH; Wesseling H; Lie KI
    Am Heart J; 1989 Feb; 117(2):365-9. PubMed ID: 2492738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summary of efficacy and safety of flecainide for supraventricular arrhythmias.
    Anderson JL; Jolivette DM; Fredell PA
    Am J Cardiol; 1988 Aug; 62(6):62D-66D. PubMed ID: 3136638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term use of flecainide in patients with supraventricular tachycardia.
    Neuss H
    Drugs; 1985; 29 Suppl 4():21-5. PubMed ID: 4006776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of tocainide, encainide, lorcainide and flecainide for supraventricular arrhythmias.
    Orning OM
    Eur Heart J; 1984 Sep; 5 Suppl B():81-6. PubMed ID: 6437821
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of flecainide in supraventricular arrhythmias].
    Chouty F; Leclercq JF; Coumel P
    Ann Cardiol Angeiol (Paris); 1986 Apr; 35(4):237-41. PubMed ID: 3740779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
    Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Bonnet P; Scala PJ; Demeyer JF
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A symposium: Supraventricular Arrhythmias: Update 1995. Boston, Massachusetts, May 6, 1995.
    Am J Cardiol; 1996 Jan; 77(3):1A-95A. PubMed ID: 8607386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.